April—Oncology start-up CerRx has licensed exclusive worldwide rights to IP developed by researchers at the John Wayne Cancer Institute, the National Institutes of Health, and Childrens Hospital Los Angeles (CHLA) related to a new method for treating cancer.
Recent Tech Transfer Deals (05/2009)
Our monthly update on technology transfer deals--licensing agreements between companies and universities or other research institutions--in the fields of life sciences, including pharmaceuticals, medical devices, in vitro diagnostics and research/analytical instrumentation and reagents.